Key FDA Committee Unanimously Recommends Its First Vaccine Since 2023
Key FDA Committee Unanimously Recommends Its First Vaccine Since 2023 A key advisory committee to the U.S. Food and Drug Administration (FDA) has unanimously recommended a new vaccine, marking the committee’s first vaccine endorsement since 2023. The decision represents an important development in vaccine innovation and public health, particularly as healthcare agencies continue to focus… Key FDA Committee Unanimously Recommends Its First Vaccine Since 2023
